Dell Technologies could emerge as a public company through a reverse-merger with VMware, the US$60 billion cloud computing company it already controls, according to CNBC.
VMware, which was absorbed by Dell in its US$67 billion acquisition of EMC, could now turn around and buy Dell, CNBC reported, citing unidentified people familiar with the matter. In a reverse merger, VMware would issue shares to Dell’s private owners, which could then sell the stock on the public market, giving them a way to profit from having taken Dell private in 2013 and to help pay off some of its US$50 billion in debt, CNBC said.
Dell, which owns about 80% of VMware, is considering various options, including a public stock offering, people familiar with the matter told Bloomberg last week. The company’s board is meeting later this month to discuss the options as it seeks ways to boost revenue and raise funds.
Dell Founder and Chief Executive Officer Michael Dell took his company private in 2013, when he teamed up with Silver Lake Management LLC on a leveraged buyout. That freed Dell to cut costs and work to become a bigger supplier of hardware and software for corporate data centers without the quarterly investor scrutiny that comes with being a public company. Three years later, Dell acquired storage-technology provider EMC and its majority stake in data-center software vendor VMware, taking on a massive debt load to seal the deal.
Full Content: CNBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas